Chris Beattie
Technik-/Wissenschafts-/F&E-Leiter bei AQUABOUNTY TECHNOLOGIES, INC.
Profil
Chris Beattie currently works at ViAqua Therapeutics Ltd., as Director from 2021 and AquaBounty Technologies, Inc., as Chief Scientific Officer from 2022.
Aktive Positionen von Chris Beattie
| Unternehmen | Position | Beginn |
|---|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 |
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Direktor/Vorstandsmitglied | 01.11.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
